Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Biopharmaceutical Statistics
|
October 31, 2014
Testing assay linearity over a pre-specified range
Harry Yang, Steven J Novick, David LeBlond
Journal of Pharmaceutical Sciences
|
October 15, 2019
Risk-Based Approach to Lot Release
Linas Mockus, Gintaras Reklaitis, Kenneth Morris, et al.
International Journal of Alzheimer'S Disease
|
May 31, 2012
The Relationship between Different Assays for Detection and Quantification of Amyloid Beta 42 in Human Cerebrospinal Fluid
Teresa A Ellis, Jinhe Li, David Leblond, et al.
AAPS Pharmscitech
|
March 5, 2011
A QbD case study: Bayesian prediction of lyophilization cycle parameters
Linas Mockus, David LeBlond, Prabir K Basu, et al.
Pharmaceutical Statistics
|
May 10, 2023
Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solution
Stan Altan, Paul Faya, Adam P Rauk, et al.
The Journal of Pain
|
May 1, 2012
Estimating efficacy and drug ED50's using von Frey thresholds: impact of weber's law and log transformation
Charles Mills, David Leblond, Shailen Joshi, et al.
The AAPS Journal
|
May 21, 2020
In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When-Workshop Summary Report
Sandra Suarez-Sharp, Andreas Abend, Thomas Hoffelder, et al.
Mabs
|
June 7, 2012
Increased serum clearance of oligomannose species present on a human IgG1 molecule
Leslie Alessandri, David Ouellette, Aima Acquah, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 4, 2011
Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels
Jinhe Li, Daniel A Llano, Teresa Ellis, et al.
AAPS Pharmscitech
|
September 27, 2017
Evaluating Current Practices in Shelf Life Estimation
Robert Capen, David Christopher, Patrick Forenzo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Biopharmaceutical Statistics
|
October 31, 2014
Testing assay linearity over a pre-specified range
Harry Yang, Steven J Novick, David LeBlond
Journal of Pharmaceutical Sciences
|
October 15, 2019
Risk-Based Approach to Lot Release
Linas Mockus, Gintaras Reklaitis, Kenneth Morris, et al.
International Journal of Alzheimer'S Disease
|
May 31, 2012
The Relationship between Different Assays for Detection and Quantification of Amyloid Beta 42 in Human Cerebrospinal Fluid
Teresa A Ellis, Jinhe Li, David Leblond, et al.
AAPS Pharmscitech
|
March 5, 2011
A QbD case study: Bayesian prediction of lyophilization cycle parameters
Linas Mockus, David LeBlond, Prabir K Basu, et al.
Pharmaceutical Statistics
|
May 10, 2023
Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solution
Stan Altan, Paul Faya, Adam P Rauk, et al.
The Journal of Pain
|
May 1, 2012
Estimating efficacy and drug ED50's using von Frey thresholds: impact of weber's law and log transformation
Charles Mills, David Leblond, Shailen Joshi, et al.
The AAPS Journal
|
May 21, 2020
In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When-Workshop Summary Report
Sandra Suarez-Sharp, Andreas Abend, Thomas Hoffelder, et al.
Mabs
|
June 7, 2012
Increased serum clearance of oligomannose species present on a human IgG1 molecule
Leslie Alessandri, David Ouellette, Aima Acquah, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 4, 2011
Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels
Jinhe Li, Daniel A Llano, Teresa Ellis, et al.
AAPS Pharmscitech
|
September 27, 2017
Evaluating Current Practices in Shelf Life Estimation
Robert Capen, David Christopher, Patrick Forenzo, et al.
Page
of 2